Pseudoexon exclusion by antisense therapy in 6-pyruvoyl-tetrahydropterin synthase deficiency
Page 1 of 1
Pseudoexon exclusion by antisense therapy in 6-pyruvoyl-tetrahydropterin synthase deficiency
Jon Moulton Thu May 05, 2011 11:22 am
Brasil S, Viecelli HM, Meili D, Rassi A, Desviat LR, Pérez B, Ugarte M, Thöny B. Pseudoexon exclusion by antisense therapy in 6-pyruvoyl-tetrahydropterin synthase deficiency. Hum Mutat. 2011 May 3. doi: 10.1002/humu.21529. [Epub ahead of print]
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease
» Antisense-Mediated Therapeutic Pseudoexon Skipping In Tmem165-Cdg
» Antisense Oligonucleotide-Based Therapy in Human Erythropoietic Protoporphyria
» Antisense modulation of RNA processing as a therapeutic approach in cancer therapy
» Antisense pre-treatment increases gene therapy efficacy in dystrophic muscles
» Antisense-Mediated Therapeutic Pseudoexon Skipping In Tmem165-Cdg
» Antisense Oligonucleotide-Based Therapy in Human Erythropoietic Protoporphyria
» Antisense modulation of RNA processing as a therapeutic approach in cancer therapy
» Antisense pre-treatment increases gene therapy efficacy in dystrophic muscles
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum|
|
|